|
No. of subjects |
231 |
119 |
112 |
|
Male, No. (%) |
127 (55.0) |
78 (65.5) |
49 (43.8) |
0.001 |
Age, mean ± SD |
55.7 ± 12.1 |
53.8 ± 12.9 |
57.7 ± 10.9 |
0.016 |
Age, No. (%) |
|
|
|
|
< 35 years |
20 (8.7) |
13 (10.9) |
7 (6.3) |
0.006 |
35–49 years |
41 (17.8) |
30 (25.2) |
11 (9.8) |
|
50–64 years |
111 (48.1) |
49 (41.2) |
62 (55.4) |
|
≥65 years |
59 (25.5) |
27 (22.7) |
32 (28.6) |
|
Race, No. (%) |
|
|
|
|
White |
165 (71.4) |
85 (71.4) |
80 (71.4) |
0.611 |
Black |
19 (8.2) |
8 (6.7) |
11 (9.8) |
|
Asian |
11 (4.8) |
8 (6.7) |
3 (2.7) |
|
Hispanic |
32 (13.9) |
16 (13.4) |
16 (14.3) |
|
Other |
4 (1.7) |
2 (1.7) |
2 (1.8) |
|
Diagnosis, No. (%) |
|
|
|
|
A (e.g. Obstructive lung disease) |
37 (16.0) |
11 (9.2) |
26 (23.2) |
0.008 |
B (e.g. Pulmonary Hypertension) |
10 (4.3) |
6 (5.0) |
4 (3.6) |
|
C (e.g. Suppurative lung disease) |
20 (8.7) |
15 (12.6) |
5 (4.5) |
|
D (e.g. Pulmonary Fibrosis) |
164 (71.0) |
87 (73.1) |
77 (68.8) |
|
BMI (kg/m2), mean ± SD |
25.5 ± 4.4 |
25.0 ± 4.3 |
26.1 ± 4.3 |
0.063 |
FEV1 % predicted, mean ± SD |
45.4 ± 20.5 |
45.9 ± 20.5 |
44.9 ± 20.5 |
0.715 |
FEV1 % predicted, median (Q1, Q3) |
46.0 (28.0, 60.0) |
45.5 (28.0, 60.0) |
46.0 (29.0, 59.0) |
0.821 |
6 MWD (m), mean ± SD |
254.4 ± 140.8 |
275.8 ± 136.3 |
231.2 ± 142.5 |
0.017 |
6 MWD (m), median (Q1, Q3) |
268.2 (142.7, 366.0) |
303.9 (159.0, 376.0) |
228.6 (134.2, 332.5) |
0.007 |
LAS at transplant, mean ± SD |
58.5 ± 21.5 |
57.4 ± 20.3 |
59.7 ± 22.6 |
0.413 |
LAS at transplant, median (Q1, Q3) |
52.0 (39.0, 79.0) |
50.0 (41.0, 72.0) |
55.0 (38.5, 84.5) |
0.750 |
Transplant type, No. (%) |
|
|
|
|
Bilateral |
215 (93.1) |
106 (89.1) |
109 (97.3) |
0.022 |
Single |
13 (5.6) |
11 (9.2) |
2 (1.8) |
|
Heart/Lung |
3 (1.3) |
2 (1.7) |
1 (0.9) |
|
Inpatient at transplant, No. (%) |
76 (32.9) |
35 (29.4) |
41 (36.6) |
0.245 |
Ventilator at transplant, No. (%) |
21 (9.1) |
13 (10.9) |
8 (7.1) |
0.317 |
ECMO at transplant, No. (%) |
18 (7.8) |
11 (9.2) |
7 (6.3) |
0.396 |
Pre-transplant SPPB, mean ± SD |
9.0 ± 3.1 |
9.7 ± 2.9 |
8.1 ± 3.0 |
<0.001 |
Pre-transplant SPPB, median (Q1, Q3) |
10.0 (8.0, 11.0) |
11.0 (9.0, 12.0) |
9.0 (7.0, 10.0) |
<0.001 |
Time to CLAD, years, median (Q1, Q3) |
2.9 (1.6, 4.5) |
3. 0 (1.8, 4.8) |
2.7 (1.2, 4.5) |
0.328 |